Obesity significantly impacts cardiovascular health, increasing risks such as left ventricular hypertrophy, atherosclerosis, ...
Bayer seeks European marketing approval for use of finerenone in adult patients with HF with a left ventricular ejection fraction (LVEF) of =40%: Berlin Tuesday, February 4, 2025, ...
Death by heartbreak doesn't just happen in stories. In real life, severe stress can cause the sometimes-fatal takotsubo syndrome.
There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...
Berlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA), ...
Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is ...
Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure ...
"AISAP is proud to collaborate with forward-thinking practices and community partners like Amavita," said Roni Attali, AISAP ...
Stockhead on MSN4d
Biocurious: EBR Systems is on a ‘glide path’ to FDA approval for its novel heart deviceCEO John McCutcheon is adamant the US Food & Drug Administration (FDA) will approve the company's Wise, the world’s first ...
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) released topline results from its Phase 2 FIGHT DMD trial. The study evaluated ...
Bhubaneswar: The Kalinga Institute of Medical Sciences (KIMS) here has become the first in Odisha to introduce the ...
The artificial intelligence model predicts patients’ heart disorders and risk of future heart failure using just an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback